FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Cantrell Drug Glycopyrrolate Injection Solution Recall

Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0

Cantrell Drug Company · Little Rock, AR

Risk level
Class II
Reported by FDA
Aug 16, 2017
Recall ID
D-1065-2017
Check your lot numberHow we source this data

Summary

Cantrell Drug recalled Glycopyrrolate Injection Solution starting Jul 14, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1065-2017 on Aug 16, 2017. Reason: Lack of Sterility Assurance. Status: Terminated.

Why it was recalled

Lack of Sterility Assurance.

Product description

Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-15

Lot numbers, UPCs & expiration codes

Lot #: 9783, BUD: 7/27/2017; 9801, BUD: 7/29/2017; 9807, BUD: 7/30/2017; 9847, BUD: 8/4/2017; 9954, BUD: 8/20/2017; 10022, BUD: 9/1/2017; 10052, BUD: 9/6/2017; 10063, BUD: 9/7/2017; 10086, BUD: 9/9/2017; 10108, BUD: 9/13/2017; 10156, BUD: 9/20/2017; 10180, BUD: 9/22/2017; 10245, BUD: 9/29/2017; 10264, BUD: 9/30/2017; 10322, BUD: 10/8/2017; 10339, BUD: 10/13/2017; 10368, BUD: 10/18/2017; 10406, BUD: 10/25/2017; 10419, BUD: 10/26/2017; 10435, BUD: 10/28/2017; 10455, BUD: 11/1/2017; 10489, BUD: 11/5/2017; 10497, BUD: 11/6/2017; 10516, BUD: 11/9/2017; 10527, BUD: 11/10/2017; 10577, BUD: 11/19/2017

Where it was sold

Nationwide within the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1065-2017
Classification
Class II
Status
Terminated
Recall initiated
Jul 14, 2017
FDA report date
Aug 16, 2017
Quantity
75840 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
Cantrell Drug Company

Original FDA data

Every field from FDA enforcement report D-1065-2017, exactly as published.

Show all FDA fields
City
Little Rock
State
AR
Status
Terminated
Country
United States
Event ID
77780
Address
7321 Cantrell Rd
Code information
Lot #: 9783, BUD: 7/27/2017; 9801, BUD: 7/29/2017; 9807, BUD: 7/30/2017; 9847, BUD: 8/4/2017; 9954, BUD: 8/20/2017; 10022, BUD: 9/1/2017; 10052, BUD: 9/6/2017; 10063, BUD: 9/7/2017; 10086, BUD: 9/9/2017; 10108, BUD: 9/13/2017; 10156, BUD: 9/20/2017; 10180, BUD: 9/22/2017; 10245, BUD: 9/29/2017; 10264, BUD: 9/30/2017; 10322, BUD: 10/8/2017; 10339, BUD: 10/13/2017; 10368, BUD: 10/18/2017; 10406, BUD: 10/25/2017; 10419, BUD: 10/26/2017; 10435, BUD: 10/28/2017; 10455, BUD: 11/1/2017; 10489, BUD: 11/5/2017; 10497, BUD: 11/6/2017; 10516, BUD: 11/9/2017; 10527, BUD: 11/10/2017; 10577, BUD: 11/19/2017
Postal code
72207-4144
Report date
Aug 16, 2017
Product type
Drugs
Recall number
D-1065-2017
Classification
Class II
Recalling firm
Cantrell Drug Company
Product quantity
75840 syringes
Termination date
Sep 16, 2020
Reason for recall
Lack of Sterility Assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-15
Distribution pattern
Nationwide within the US
Recall initiation date
Jul 14, 2017
Initial firm notification
Letter
Center classification date
Aug 9, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1065-2017, published Aug 16, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls